Entheon Biomedical Corp. / Federal — Form D

Entheon Biomedical Corp. / Federal of COQUITLAM, A1, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-03. The offering totals $1.7M, of which $31K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-02-03
• Form: D
• Accession: 0001843655-21-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $1.7M
• Amount sold: $31K
• Remaining: $1.7M
• Investors: 1
• Date of first sale: 2021-01-11
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-388338

Issuer

• Name: Entheon Biomedical Corp. / Federal
• CIK: 0001843655
• Entity type: Corporation
• Jurisdiction: CANADA (FEDERAL LEVEL)
• Address: 211-3030 LINCOLN AVENUE, COQUITLAM, A1, V3B 6B4
• Phone: 604-562-3932

Officers, directors & promoters (8)

More

• CIK 1843655 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search